Stock price when the opinion was issued
Has been very negative on this name. Thematically they have incurred a ton of debt to develop oil sands and when you are the marginal cost barrel in the oil sands and financing it with debt, it is a risky business and it didn’t work out for them. Have gone through a process of management change, selling assets, etc. Still have a lot of challenges ahead.
Largely in the lab testing business and their largest client is the Ontario government. Major risk is the Ontario government’s $14 billion deficit deciding that they are going to squeeze the lab companies. It will probably be another year before you know.